Oral solid medicine composition for nervous system diseases

A technology of materials and adhesives, applied in nervous system diseases, drug combinations, cardiovascular system diseases, etc., can solve problems such as left ventricular enlargement and reduction, achieve elimination of half-life, improve brain energy metabolism, and inhibit brain mitochondria to generate peroxidation The effect of lipids
CN103040779BActive Publication Date: 2015-04-15北京利龄恒泰药业有限公司
4 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
北京利龄恒泰药业有限公司
Publication Date
2015-04-15

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to an oral solid medicine composition for nervous system diseases. The composition is a tablet and comprises an active component, lactose anhydrous, a disintegrating agent and an adhesive. The medicine composition can be used for a cerebrovascular disease, used for improving brain metabolism and mental symptoms, activating respiratory activity of brain mitochondria, improving brain energy metabolism of brain ischemia, increasing a utilization ratio of glucose in a brain, allowing adenosine triphosphate produced in the brain to be increased, preventing brain mitochondrion from generating peroxidized lipin, and inhibiting a membrane obstruction due to lipid peroxidation of a brain mitochondrial membrane, used for brain function injures caused by the chronic cerebrovascular disease, brain trauma and the like, and used for improving mental and behavioral disorders such as a subjective symptom, a language disorder, anxiety, depression, hypomnesia and brain power declining, promoting brain power, activating a brain mitochondrion function, improving the brain energy metabolism and a brain function, improving emotion depression, low consciousness, an affective disorder, a language disorder and the like that are caused by a cerebral infarction sequela, a cerebral hemorrhage sequela and cerebral arteriosclerosis, improving brain metabolism, and protecting cranial neural cells.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field

[0001] The invention relates to an oral solid pharmaceutical composition for nervous system diseases. Background technique

[0002] Neuronal damage, neurodegenerative diseases and syndromes (Alzheimer's disease, multiple sclerosis, Friedrich's ataxia), brain and spinal cord injuries and neurotraumatic injuries, stroke, Parkinson's disease, alcoholism And narcolepsy (narcolepsy), postoperative recovery syndrome and post-anaesthesia recovery syndrome) and many other diseases require effective treatment and prevention.

[0003] Postoperative stroke and cognitive deficit (POSCD) syndrome is common, especially in elderly people undergoing extensive surgical procedures such as heart surgery or hip replacement surgery. In North America, more than 2.5 million such surgical procedures are performed each year, and the incidence of POSCD exceeds 30%. There is an urgent need for interventional therapy, and there are not enough treatment options for this painful postoperative ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More